Clinical Trial

Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency

Study acronym: VaraD-Cell
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 25, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Preclinical evaluation of a vitamin D analog for the treatment of vitamin D 24-hydroxylase using fibroblast from patients with CYP24A1 mutation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-07-23.
Status change: Enrolling by Invitation → Recruiting 2025-07-22
Trial Details
NCT Number NCT04987073
Lead Sponsor University Hospital, Caen
Conditions Idiopathic Infantile Hypercalcemia - Severe Form
Enrollment 30 participants
Start Date 2022-07-17
Primary Completion 2026-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-25